The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 164:1557-1560, October 2007
doi: 10.1176/appi.ajp.2007.07020233
© 2007 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Venkatasubramanian, G.
* Articles by Shetty, K. T.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Venkatasubramanian, G.
* Articles by Shetty, K. T.
Related Collections
* Neuroendocrinology
* Schizophrenia Spectrum Disorders

Insulin and Insulin-Like Growth Factor-1 Abnormalities in Antipsychotic-Naive Schizophrenia

Ganesan Venkatasubramanian, M.D., Seetharamaiah Chittiprol, Ph.D., Narendran Neelakantachar, M.B.B.S., Magadi N. Naveen, M.D., Jagadisha Thirthall, M.D., Bangalore N. Gangadhar, M.D., and K. Taranath Shetty, Ph.D.

OBJECTIVE: The purpose of this study was to examine the evidence for the insulin-like growth factor-1 (IGF-1) deficiency hypothesis in the pathogenesis of schizophrenia. METHOD: The authors examined the fasting plasma levels of glucose, insulin, IGF-1, and cortisol in antipsychotic-naive schizophrenia patients (N=44) relative to age- and sex-matched healthy comparison subjects (N=44). Patients and comparison subjects were also matched for anthropometric measures and physical activity. RESULTS: Schizophrenia patients had a significantly higher mean plasma insulin level as well as a significantly higher mean insulin resistance score relative to healthy comparison subjects. The mean plasma IGF-1 level was significantly lower in patients. IGF-1 levels had a significant negative correlation with plasma insulin levels. The total positive symptoms score as well as the hallucinations subscore had a significant inverse relationship with IGF-1 levels. CONCLUSIONS: Deficient IGF-1 might underlie insulin resistance in schizophrenia. The IGF-1 deficit in antipsychotic-naive schizophrenia patients and its significant correlation with psychopathology scores suggest that IGF-1 might be potentially involved in the pathogenesis of schizophrenia.




This article has been cited by other articles:


Home page
JAMAHome page
G. Venkatasubramanian
Antipsychotic-Induced Weight Gain in Patients With Schizophrenia
JAMA, April 23, 2008; 299(16): 1899 - 1899.
[Full Text] [PDF]


Home page
Schizophr BullHome page
B. Kirkpatrick, E. Messias, P. D. Harvey, E. Fernandez-Egea, and C. R. Bowie
Is Schizophrenia a Syndrome of Accelerated Aging?
Schizophr Bull, December 21, 2007; (2007) sbm140v1.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org